Published in

Taylor and Francis Group, Expert Opinion on Investigational Drugs, 12(30), p. 1209-1219, 2021

DOI: 10.1080/13543784.2022.2022119

Links

Tools

Export citation

Search in Google Scholar

Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes

Journal article published in 2021 by Carmen Mignogna, Ernesto Maddaloni, Luca D’Onofrio ORCID, Raffaella Buzzetti
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO